These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7978838)

  • 41. Type IV collagen induces matrix metalloproteinase 2 activation in HT1080 fibrosarcoma cells.
    Maquoi E; Frankenne F; Noël A; Krell HW; Grams F; Foidart JM
    Exp Cell Res; 2000 Dec; 261(2):348-59. PubMed ID: 11112341
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells.
    Aznavoorian S; Moore BA; Alexander-Lister LD; Hallit SL; Windsor LJ; Engler JA
    Cancer Res; 2001 Aug; 61(16):6264-75. PubMed ID: 11507081
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2.
    Deryugina EI; Bourdon MA; Reisfeld RA; Strongin A
    Cancer Res; 1998 Aug; 58(16):3743-50. PubMed ID: 9721888
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.
    Lim YT; Sugiura Y; Laug WE; Sun B; Garcia A; DeClerck YA
    J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.
    Mackay AR; Ballin M; Pelina MD; Farina AR; Nason AM; Hartzler JL; Thorgeirsson UP
    Invasion Metastasis; 1992; 12(3-4):168-84. PubMed ID: 1284126
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour necrosis factor-alpha fusion protein.
    Chandler S; Cossins J; Lury J; Wells G
    Biochem Biophys Res Commun; 1996 Nov; 228(2):421-9. PubMed ID: 8920930
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines.
    Afzal S; Lalani el-N ; Foulkes WD; Boyce B; Tickle S; Cardillo MR; Baker T; Pignatelli M; Stamp GW
    Lab Invest; 1996 Feb; 74(2):406-21. PubMed ID: 8780160
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Elevated levels of Mr 92,000 type IV collagenase during tumor growth in vivo.
    Sawaya R; Go Y; Kyritisis AP; Uhm J; Venkaiah B; Mohanam S; Gokaslan ZL; Rao JS
    Biochem Biophys Res Commun; 1998 Oct; 251(2):632-6. PubMed ID: 9792825
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Different expression patterns of MMP-2 and MMP-9 in breast cancer.
    Rha SY; Yang WI; Kim JH; Roh JK; Min JS; Lee KS; Kim BS; Chung HC
    Oncol Rep; 1998; 5(4):875-9. PubMed ID: 9625836
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9.
    Ochieng J; Fridman R; Nangia-Makker P; Kleiner DE; Liotta LA; Stetler-Stevenson WG; Raz A
    Biochemistry; 1994 Nov; 33(47):14109-14. PubMed ID: 7947821
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A possible role for MMP-2 and MMP-9 in the migration of primate arterial smooth muscle cells through native matrix.
    Kenagy RD; Clowes AW
    Ann N Y Acad Sci; 1994 Sep; 732():462-5. PubMed ID: 7526763
    [No Abstract]   [Full Text] [Related]  

  • 52. Membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation in primary human ovarian epithelial carcinoma cells.
    Fishman DA; Bafetti LM; Stack MS
    Invasion Metastasis; 1996; 16(3):150-9. PubMed ID: 9186550
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stromelysin-1/matrix metalloproteinase-3 (MMP-3) expression accounts for invasive properties of human astrocytoma cell lines.
    Mercapide J; Lopez De Cicco R; Castresana JS; Klein-Szanto AJ
    Int J Cancer; 2003 Sep; 106(5):676-82. PubMed ID: 12866026
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Selection of potentially metastatic subpopulations expressing c-erbB-2 from breast cancer tissue by use of an extravasation model.
    Roetger A; Merschjann A; Dittmar T; Jackisch C; Barnekow A; Brandt B
    Am J Pathol; 1998 Dec; 153(6):1797-806. PubMed ID: 9846970
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heat shock suppresses membrane type 1-matrix metalloproteinase production and progelatinase A activation in human fibrosarcoma HT-1080 cells and thereby inhibits cellular invasion.
    Sato T; Sawaji Y; Matsui N; Sato H; Seiki M; Mori Y; Ito A
    Biochem Biophys Res Commun; 1999 Nov; 265(1):189-93. PubMed ID: 10548512
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Molecular mechanism of invadopodia formation].
    Nakahara H
    Tanpakushitsu Kakusan Koso; 1998 Apr; 43(5):669-75. PubMed ID: 9564784
    [No Abstract]   [Full Text] [Related]  

  • 57. Relationship between matrix metalloproteinase expression and tumor angiogenesis in human breast carcinoma.
    Kurizaki T; Toi M; Tominaga T
    Oncol Rep; 1998; 5(3):673-7. PubMed ID: 9538174
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Molecular aspects of urological cancers].
    Kagawa S
    Nihon Hinyokika Gakkai Zasshi; 1995 May; 86(5):963-78. PubMed ID: 7541091
    [No Abstract]   [Full Text] [Related]  

  • 59. Matrix metalloproteinases and carcinogenesis.
    Rodgers W
    Hum Pathol; 1999 Apr; 30(4):363-4. PubMed ID: 10208454
    [No Abstract]   [Full Text] [Related]  

  • 60. Protein kinase C and breast cancer.
    Davidson NE; Kennedy MJ
    Cancer Treat Res; 1996; 83():91-105. PubMed ID: 8826643
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.